retatrutide liver safety Since January 2026, there have been six cases of acute toxicity associated with unapproved peptide products labelled in Australia. These toxic effects may be linked to a contaminant in the RACGP - Illegal peptide warnings

Prescription requirements include documented BMI criteria (30+ or 27+ with comorbidities), typically requiring physician assessment and ongoing monitoring

However, the results of clinical trials suggest that the characteristics of the cardiorenal protective effects achieved by these drugs differ slightly, and consensus for their use and evidence for their optimal use and combined benefits are still lacking

He has a BA in Government from Harvard, where he was named a John Harvard Scholar and wrote op-eds like Shut Down Harvard Football, which he tells us were great for his social life

By six months, the participants had lost 12.7% of their body weight on average

Participants who continued treatment beyond initial trial periods maintained their weight loss without needing dose increases